These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19043742)

  • 1. Stability of an extemporaneous oral liquid aprepitant formulation.
    Dupuis LL; Lingertat-Walsh K; Walker SE
    Support Care Cancer; 2009 Jun; 17(6):701-6. PubMed ID: 19043742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of extemporaneously compounded temozolomide 10 mg/mL suspensions in Oral Mix SF® in glass and plastic bottles and plastic syringes.
    Lingertat-Walsh K; Weilnau J; Cober MP; Ostrenga A; Poon B; Sales P; Law S; Dupuis LL; Walker SE
    J Oncol Pharm Pract; 2021 Jan; 27(1):78-87. PubMed ID: 32228132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of Extemporaneously Prepared Hydroxychloroquine Sulfate 25-mg/mL Suspensions in Plastic Bottles and Syringes.
    McHenry AR; Wempe MF; Rice PJ
    Int J Pharm Compd; 2017; 21(3):251-254. PubMed ID: 28557788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of Extemporaneously Compounded Nadolol 10-mg/mL Suspension in Oral Mix in Glass and Plastic Bottles and Plastic Syringes.
    Walsh A; Ziegler B; Lingertat-Walsh K; Law S; Walker SE
    Int J Pharm Compd; 2021; 25(2):163-168. PubMed ID: 33798116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of extemporaneously prepared cinacalcet oral suspensions.
    Thomson K; Hutchinson DJ; Chablani L
    Am J Health Syst Pharm; 2018 May; 75(9):e236-e240. PubMed ID: 29691267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of Extemporaneously Compounded Domperidone 5 mg/mL Suspension in Oral Mix in Plastic and Glass Bottles and Plastic Syringes.
    Lingertat-Walsh K; Law S; Walker SE
    Can J Hosp Pharm; 2018; 71(3):165-172. PubMed ID: 29955189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and stability of extemporaneous oral liquid formulations of oseltamivir using commercially available capsules.
    Winiarski AP; Infeld MH; Tscherne R; Bachynsky M; Rucki R; Nagano-Mate K
    J Am Pharm Assoc (2003); 2007; 47(6):747-55. PubMed ID: 18032138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Dexamethasone Sodium Phosphate.
    Wu G; Yeung S; Chen F
    Int J Pharm Compd; 2017; 21(1):66-75. PubMed ID: 28346199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride.
    Wu G; Powers D; Yeung S; Chen F; Neelon K
    Int J Pharm Compd; 2018; 22(1):86-94. PubMed ID: 29385389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of dolasetron in two oral liquid vehicles.
    Johnson CE; Wagner DS; Bussard WE
    Am J Health Syst Pharm; 2003 Nov; 60(21):2242-4. PubMed ID: 14619116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection.
    Wu G; Powers D; Yeung S; Chen F
    Int J Pharm Compd; 2018; 22(1):76-85. PubMed ID: 29385388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of flucytosine in an extemporaneously compounded oral liquid.
    Wintermeyer SM; Nahata MC
    Am J Health Syst Pharm; 1996 Feb; 53(4):407-9. PubMed ID: 8673661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term Stability of a Compounded Suspension of Torsemide (5 mg/mL) for Oral Administration.
    Adin D; Johnson PR; Kim CH; Nguyenba T; Rosen S
    J Vet Intern Med; 2017 Nov; 31(6):1822-1826. PubMed ID: 28913839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of an extemporaneously prepared thalidomide suspension.
    Kraft S; Johnson CE; Tyler RP
    Am J Health Syst Pharm; 2012 Jan; 69(1):56-8. PubMed ID: 22180553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of extemporaneously compounded dexamethasone in glass and plastic bottles and plastic syringes.
    Ensom MH; Décarie D
    Can J Hosp Pharm; 2014 Jul; 67(4):274-9. PubMed ID: 25214658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of epinephrine hydrochloride in an extemporaneously compounded topical anesthetic solution of lidocaine, racepinephrine, and tetracaine.
    Larson TA; Uden DL; Schilling CG
    Am J Health Syst Pharm; 1996 Mar; 53(6):659-62. PubMed ID: 8800972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of extemporaneously prepared rifaximin oral suspensions.
    Cober MP; Johnson CE; Lee J; Currie K
    Am J Health Syst Pharm; 2010 Feb; 67(4):287-9. PubMed ID: 20133533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of an extemporaneous liquid formulation of lisinopril.
    Thompson KC; Zhao Z; Mazakas JM; Beasley CA; Reed RA; Moser CL
    Am J Health Syst Pharm; 2003 Jan; 60(1):69-74. PubMed ID: 12533979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride.
    Wu G; Yeung S; Chen F
    Int J Pharm Compd; 2017; 21(1):76-82. PubMed ID: 28346200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of reconstituted fluconazole oral suspension in plastic bottles and oral syringes.
    Dentinger PJ; Swenson CF
    Ann Pharmacother; 2009 Mar; 43(3):485-9. PubMed ID: 19208778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.